Status: current, Sufficiently defined by necessary conditions definition status. Date: 30-Sep 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5110574017 | Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT core module |
| 5110575016 | Levamlodipine (as levamlodipine besylate) 5 mg and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 5110576015 | Levamlodipine (as levamlodipine besilate) 5 mg and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Is a | Product containing only levamlodipine and metoprolol in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has manufactured dose form | Conventional release and prolonged-release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has precise active ingredient | Levamlodipine besilate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has basis of strength substance | Levamlodipine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has precise active ingredient | (S)-metoprolol succinate | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has basis of strength substance | (S)-metoprolol tartrate | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR